Global Cell and Gene Therapy Manufacturing Services Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size 2017-2028

2.1.2 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cell and Gene Therapy Manufacturing Services Segment by Type

2.2.1 Allogeneic

2.2.2 Autologous

2.2.3 Viral Vector

2.3 Cell and Gene Therapy Manufacturing Services Market Size by Type

2.3.1 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2022)

2.4 Cell and Gene Therapy Manufacturing Services Segment by Application

2.4.1 Oncology Diseases

2.4.2 Cardiovascular Diseases

2.4.3 Orthopedic Diseases

2.4.4 Ophthalmology Diseases

2.4.5 Infectious Diseases

2.4.6 Others

2.5 Cell and Gene Therapy Manufacturing Services Market Size by Application

2.5.1 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2022)

3 Cell and Gene Therapy Manufacturing Services Market Size by Player

3.1 Cell and Gene Therapy Manufacturing Services Market Size Market Share by Players

3.1.1 Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2020-2022)

3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2020-2022)

3.2 Global Cell and Gene Therapy Manufacturing Services Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cell and Gene Therapy Manufacturing Services by Regions

4.1 Cell and Gene Therapy Manufacturing Services Market Size by Regions (2017-2022)

4.2 Americas Cell and Gene Therapy Manufacturing Services Market Size Growth (2017-2022)

4.3 APAC Cell and Gene Therapy Manufacturing Services Market Size Growth (2017-2022)

4.4 Europe Cell and Gene Therapy Manufacturing Services Market Size Growth (2017-2022)

4.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)

5.2 Americas Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)

5.3 Americas Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022)

6.2 APAC Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)

6.3 APAC Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cell and Gene Therapy Manufacturing Services by Country (2017-2022)

7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)

7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services by Region (2017-2022)

8.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)

8.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cell and Gene Therapy Manufacturing Services Market Forecast

10.1 Global Cell and Gene Therapy Manufacturing Services Forecast by Regions (2023-2028)

10.1.1 Global Cell and Gene Therapy Manufacturing Services Forecast by Regions (2023-2028)

10.1.2 Americas Cell and Gene Therapy Manufacturing Services Forecast

10.1.3 APAC Cell and Gene Therapy Manufacturing Services Forecast

10.1.4 Europe Cell and Gene Therapy Manufacturing Services Forecast

10.1.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Forecast

10.2 Americas Cell and Gene Therapy Manufacturing Services Forecast by Country (2023-2028)

10.2.1 United States Cell and Gene Therapy Manufacturing Services Market Forecast

10.2.2 Canada Cell and Gene Therapy Manufacturing Services Market Forecast

10.2.3 Mexico Cell and Gene Therapy Manufacturing Services Market Forecast

10.2.4 Brazil Cell and Gene Therapy Manufacturing Services Market Forecast

10.3 APAC Cell and Gene Therapy Manufacturing Services Forecast by Region (2023-2028)

10.3.1 China Cell and Gene Therapy Manufacturing Services Market Forecast

10.3.2 Japan Cell and Gene Therapy Manufacturing Services Market Forecast

10.3.3 Korea Cell and Gene Therapy Manufacturing Services Market Forecast

10.3.4 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Forecast

10.3.5 India Cell and Gene Therapy Manufacturing Services Market Forecast

10.3.6 Australia Cell and Gene Therapy Manufacturing Services Market Forecast

10.4 Europe Cell and Gene Therapy Manufacturing Services Forecast by Country (2023-2028)

10.4.1 Germany Cell and Gene Therapy Manufacturing Services Market Forecast

10.4.2 France Cell and Gene Therapy Manufacturing Services Market Forecast

10.4.3 UK Cell and Gene Therapy Manufacturing Services Market Forecast

10.4.4 Italy Cell and Gene Therapy Manufacturing Services Market Forecast

10.4.5 Russia Cell and Gene Therapy Manufacturing Services Market Forecast

10.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Forecast by Region (2023-2028)

10.5.1 Egypt Cell and Gene Therapy Manufacturing Services Market Forecast

10.5.2 South Africa Cell and Gene Therapy Manufacturing Services Market Forecast

10.5.3 Israel Cell and Gene Therapy Manufacturing Services Market Forecast

10.5.4 Turkey Cell and Gene Therapy Manufacturing Services Market Forecast

10.5.5 GCC Countries Cell and Gene Therapy Manufacturing Services Market Forecast

10.6 Global Cell and Gene Therapy Manufacturing Services Forecast by Type (2023-2028)

10.7 Global Cell and Gene Therapy Manufacturing Services Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Information

11.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offered

11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Thermo Fisher Scientific Main Business Overview

11.1.5 Thermo Fisher Scientific Latest Developments

11.2 Merck KGaA

11.2.1 Merck KGaA Company Information

11.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offered

11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Merck KGaA Main Business Overview

11.2.5 Merck KGaA Latest Developments

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Information

11.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offered

11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Charles River Laboratories Main Business Overview

11.3.5 Charles River Laboratories Latest Developments

11.4 Lonza

11.4.1 Lonza Company Information

11.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Offered

11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Lonza Main Business Overview

11.4.5 Lonza Latest Developments

11.5 Catalent

11.5.1 Catalent Company Information

11.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Offered

11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Catalent Main Business Overview

11.5.5 Catalent Latest Developments

11.6 WuXi AppTec

11.6.1 WuXi AppTec Company Information

11.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offered

11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 WuXi AppTec Main Business Overview

11.6.5 WuXi AppTec Latest Developments

11.7 Takara Bio Inc

11.7.1 Takara Bio Inc Company Information

11.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offered

11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Takara Bio Inc Main Business Overview

11.7.5 Takara Bio Inc Latest Developments

11.8 Nikon Corporation

11.8.1 Nikon Corporation Company Information

11.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offered

11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Nikon Corporation Main Business Overview

11.8.5 Nikon Corporation Latest Developments

11.9 FUJIFILM Holdings Corporation

11.9.1 FUJIFILM Holdings Corporation Company Information

11.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offered

11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 FUJIFILM Holdings Corporation Main Business Overview

11.9.5 FUJIFILM Holdings Corporation Latest Developments

11.10 F. Hoffmann-La Roche

11.10.1 F. Hoffmann-La Roche Company Information

11.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offered

11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 F. Hoffmann-La Roche Main Business Overview

11.10.5 F. Hoffmann-La Roche Latest Developments

11.11 Oxford Biomedica Plc

11.11.1 Oxford Biomedica Plc Company Information

11.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offered

11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Oxford Biomedica Plc Main Business Overview

11.11.5 Oxford Biomedica Plc Latest Developments

11.12 Cell and Gene Therapy Catapult

11.12.1 Cell and Gene Therapy Catapult Company Information

11.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offered

11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Cell and Gene Therapy Catapult Main Business Overview

11.12.5 Cell and Gene Therapy Catapult Latest Developments

11.13 The Discovery Labs LLC

11.13.1 The Discovery Labs LLC Company Information

11.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offered

11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 The Discovery Labs LLC Main Business Overview

11.13.5 The Discovery Labs LLC Latest Developments

11.14 RoslinCT

11.14.1 RoslinCT Company Information

11.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Offered

11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 RoslinCT Main Business Overview

11.14.5 RoslinCT Latest Developments

11.15 JRS PHARMA

11.15.1 JRS PHARMA Company Information

11.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offered

11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 JRS PHARMA Main Business Overview

11.15.5 JRS PHARMA Latest Developments

11.16 FinVector

11.16.1 FinVector Company Information

11.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Offered

11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 FinVector Main Business Overview

11.16.5 FinVector Latest Developments

11.17 ABL

11.17.1 ABL Company Information

11.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Offered

11.17.3 ABL Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 ABL Main Business Overview

11.17.5 ABL Latest Developments

11.18 Resilience

11.18.1 Resilience Company Information

11.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Offered

11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Resilience Main Business Overview

11.18.5 Resilience Latest Developments

11.19 BioCentriq

11.19.1 BioCentriq Company Information

11.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Offered

11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 BioCentriq Main Business Overview

11.19.5 BioCentriq Latest Developments

11.20 Porton Biopharma Limited

11.20.1 Porton Biopharma Limited Company Information

11.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offered

11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Porton Biopharma Limited Main Business Overview

11.20.5 Porton Biopharma Limited Latest Developments

11.21 Andelyn Biosciences

11.21.1 Andelyn Biosciences Company Information

11.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offered

11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Andelyn Biosciences Main Business Overview

11.21.5 Andelyn Biosciences Latest Developments

11.22 Commercializing Living Therapies

11.22.1 Commercializing Living Therapies Company Information

11.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offered

11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Commercializing Living Therapies Main Business Overview

11.22.5 Commercializing Living Therapies Latest Developments

11.23 Vibalogics

11.23.1 Vibalogics Company Information

11.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Offered

11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.23.4 Vibalogics Main Business Overview

11.23.5 Vibalogics Latest Developments

11.24 Anemocyte Srl

11.24.1 Anemocyte Srl Company Information

11.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offered

11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.24.4 Anemocyte Srl Main Business Overview

11.24.5 Anemocyte Srl Latest Developments

11.25 ElevateBio

11.25.1 ElevateBio Company Information

11.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Offered

11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2020-2022)

11.25.4 ElevateBio Main Business Overview

11.25.5 ElevateBio Latest Developments

12 Research Findings and Conclusion

Table 1. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Allogeneic

Table 3. Major Players of Autologous

Table 4. Major Players of Viral Vector

Table 5. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2022)

Table 8. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2022)

Table 11. Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Player (2020-2022)

Table 13. Cell and Gene Therapy Manufacturing Services Key Players Head office and Products Offered

Table 14. Cell and Gene Therapy Manufacturing Services Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Cell and Gene Therapy Manufacturing Services Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Regions (2017-2022)

Table 19. Americas Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country (2017-2022)

Table 21. Americas Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2022)

Table 23. Americas Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2022)

Table 25. APAC Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2017-2022)

Table 27. APAC Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2022)

Table 29. APAC Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2022)

Table 31. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country (2017-2022)

Table 33. Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2022)

Table 35. Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Manufacturing Services

Table 44. Key Market Challenges & Risks of Cell and Gene Therapy Manufacturing Services

Table 45. Key Industry Trends of Cell and Gene Therapy Manufacturing Services

Table 46. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Application (2023-2028)

Table 52. Thermo Fisher Scientific Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 53. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offered

Table 54. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Thermo Fisher Scientific Main Business

Table 56. Thermo Fisher Scientific Latest Developments

Table 57. Merck KGaA Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 58. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offered

Table 59. Merck KGaA Main Business

Table 60. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Merck KGaA Latest Developments

Table 62. Charles River Laboratories Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 63. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offered

Table 64. Charles River Laboratories Main Business

Table 65. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Charles River Laboratories Latest Developments

Table 67. Lonza Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 68. Lonza Cell and Gene Therapy Manufacturing Services Product Offered

Table 69. Lonza Main Business

Table 70. Lonza Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Lonza Latest Developments

Table 72. Catalent Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 73. Catalent Cell and Gene Therapy Manufacturing Services Product Offered

Table 74. Catalent Main Business

Table 75. Catalent Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Catalent Latest Developments

Table 77. WuXi AppTec Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 78. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offered

Table 79. WuXi AppTec Main Business

Table 80. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. WuXi AppTec Latest Developments

Table 82. Takara Bio Inc Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 83. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offered

Table 84. Takara Bio Inc Main Business

Table 85. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Takara Bio Inc Latest Developments

Table 87. Nikon Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 88. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offered

Table 89. Nikon Corporation Main Business

Table 90. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Nikon Corporation Latest Developments

Table 92. FUJIFILM Holdings Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 93. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offered

Table 94. FUJIFILM Holdings Corporation Main Business

Table 95. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. FUJIFILM Holdings Corporation Latest Developments

Table 97. F. Hoffmann-La Roche Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 98. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offered

Table 99. F. Hoffmann-La Roche Main Business

Table 100. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. F. Hoffmann-La Roche Latest Developments

Table 102. Oxford Biomedica Plc Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 103. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offered

Table 104. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Oxford Biomedica Plc Main Business

Table 106. Oxford Biomedica Plc Latest Developments

Table 107. Cell and Gene Therapy Catapult Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 108. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offered

Table 109. Cell and Gene Therapy Catapult Main Business

Table 110. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Cell and Gene Therapy Catapult Latest Developments

Table 112. The Discovery Labs LLC Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 113. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offered

Table 114. The Discovery Labs LLC Main Business

Table 115. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. The Discovery Labs LLC Latest Developments

Table 117. RoslinCT Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 118. RoslinCT Cell and Gene Therapy Manufacturing Services Product Offered

Table 119. RoslinCT Main Business

Table 120. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. RoslinCT Latest Developments

Table 122. JRS PHARMA Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 123. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offered

Table 124. JRS PHARMA Main Business

Table 125. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. JRS PHARMA Latest Developments

Table 127. FinVector Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 128. FinVector Cell and Gene Therapy Manufacturing Services Product Offered

Table 129. FinVector Main Business

Table 130. FinVector Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. FinVector Latest Developments

Table 132. ABL Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 133. ABL Cell and Gene Therapy Manufacturing Services Product Offered

Table 134. ABL Main Business

Table 135. ABL Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. ABL Latest Developments

Table 137. Resilience Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 138. Resilience Cell and Gene Therapy Manufacturing Services Product Offered

Table 139. Resilience Main Business

Table 140. Resilience Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Resilience Latest Developments

Table 142. BioCentriq Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 143. BioCentriq Cell and Gene Therapy Manufacturing Services Product Offered

Table 144. BioCentriq Main Business

Table 145. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. BioCentriq Latest Developments

Table 147. Porton Biopharma Limited Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 148. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offered

Table 149. Porton Biopharma Limited Main Business

Table 150. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 151. Porton Biopharma Limited Latest Developments

Table 152. Andelyn Biosciences Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 153. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offered

Table 154. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 155. Andelyn Biosciences Main Business

Table 156. Andelyn Biosciences Latest Developments

Table 157. Commercializing Living Therapies Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 158. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offered

Table 159. Commercializing Living Therapies Main Business

Table 160. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 161. Commercializing Living Therapies Latest Developments

Table 162. Vibalogics Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 163. Vibalogics Cell and Gene Therapy Manufacturing Services Product Offered

Table 164. Vibalogics Main Business

Table 165. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 166. Vibalogics Latest Developments

Table 167. Anemocyte Srl Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 168. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offered

Table 169. Anemocyte Srl Main Business

Table 170. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 171. Anemocyte Srl Latest Developments

Table 172. ElevateBio Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors

Table 173. ElevateBio Cell and Gene Therapy Manufacturing Services Product Offered

Table 174. ElevateBio Main Business

Table 175. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 176. ElevateBio Latest Developments

List of Figures

Figure 1. Cell and Gene Therapy Manufacturing Services Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2021

Figure 7. Cell and Gene Therapy Manufacturing Services in Oncology Diseases

Figure 8. Global Cell and Gene Therapy Manufacturing Services Market: Oncology Diseases (2017-2022) & ($ Millions)

Figure 9. Cell and Gene Therapy Manufacturing Services in Cardiovascular Diseases

Figure 10. Global Cell and Gene Therapy Manufacturing Services Market: Cardiovascular Diseases (2017-2022) & ($ Millions)

Figure 11. Cell and Gene Therapy Manufacturing Services in Orthopedic Diseases

Figure 12. Global Cell and Gene Therapy Manufacturing Services Market: Orthopedic Diseases (2017-2022) & ($ Millions)

Figure 13. Cell and Gene Therapy Manufacturing Services in Ophthalmology Diseases

Figure 14. Global Cell and Gene Therapy Manufacturing Services Market: Ophthalmology Diseases (2017-2022) & ($ Millions)

Figure 15. Cell and Gene Therapy Manufacturing Services in Infectious Diseases

Figure 16. Global Cell and Gene Therapy Manufacturing Services Market: Infectious Diseases (2017-2022) & ($ Millions)

Figure 17. Cell and Gene Therapy Manufacturing Services in Others

Figure 18. Global Cell and Gene Therapy Manufacturing Services Market: Others (2017-2022) & ($ Millions)

Figure 19. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2021

Figure 20. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Player in 2021

Figure 21. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Regions (2017-2022)

Figure 22. Americas Cell and Gene Therapy Manufacturing Services Market Size 2017-2022 ($ Millions)

Figure 23. APAC Cell and Gene Therapy Manufacturing Services Market Size 2017-2022 ($ Millions)

Figure 24. Europe Cell and Gene Therapy Manufacturing Services Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size 2017-2022 ($ Millions)

Figure 26. Americas Cell and Gene Therapy Manufacturing Services Value Market Share by Country in 2021

Figure 27. Americas Cell and Gene Therapy Manufacturing Services Consumption Market Share by Type in 2021

Figure 28. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2021

Figure 29. United States Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region in 2021

Figure 34. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2021

Figure 35. China Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 39. India Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country in 2021

Figure 42. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2021

Figure 43. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2021

Figure 44. Germany Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 45. France Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2021

Figure 52. Egypt Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country Cell and Gene Therapy Manufacturing Services Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 58. APAC Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 59. Europe Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 61. United States Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 62. Canada Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 63. Mexico Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 64. Brazil Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 65. China Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 66. Japan Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 67. Korea Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 69. India Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 70. Australia Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 71. Germany Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 72. France Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 73. UK Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 74. Italy Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 75. Russia Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 76. Spain Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 77. Egypt Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 78. South Africa Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 79. Israel Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 80. Turkey Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries Cell and Gene Therapy Manufacturing Services Market Size 2023-2028 ($ Millions)